Pfizer Ltd. — Investor Relations & Filings
Pfizer Ltd. is a leading biopharmaceutical company focused on the discovery, development, and manufacture of innovative healthcare products. The company offers a diverse portfolio of medicines and vaccines across several therapeutic areas, including oncology, inflammation and immunology, rare diseases, internal medicine, and anti-infectives. Key products include advanced treatments for cardiovascular health, respiratory conditions, and various infectious diseases. Pfizer Ltd. leverages global research and development capabilities to provide high-quality, science-based solutions aimed at improving patient outcomes and addressing unmet medical needs. The company maintains a significant presence in the market through its commitment to scientific excellence and a robust pipeline of next-generation therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-07-07 | English | |
| Change in Management | 2025-07-02 | English | |
| General Updates | 2025-06-30 | English | |
| Copy of Newspaper Publication | 2025-06-30 | English | |
| Trading Window | 2025-06-30 | English | |
| Shareholders meeting | 2025-06-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42335540 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-07-07 | English | ||
| 42319184 | Change in Management | 2025-07-02 | English | ||
| 42340479 | General Updates | 2025-06-30 | English | ||
| 42342842 | Copy of Newspaper Publication | 2025-06-30 | English | ||
| 42342918 | Trading Window | 2025-06-30 | English | ||
| 42353350 | Shareholders meeting | 2025-06-29 | English | ||
| 42392223 | General Updates | 2025-05-19 | English | ||
| 42392410 | Updates | 2025-05-19 | English | ||
| 42392467 | Record Date | 2025-05-19 | English | ||
| 42392522 | Outcome of Board Meeting | 2025-05-19 | English | ||
| 43921930 | Board Meeting — Board Meeting Intimation | 2025-05-13 | English | ||
| 43921969 | Board Meeting — Financial Results/Dividend | 2025-05-13 | English | ||
| 42444817 | Disclosure under SEBI Takeover Regulations | 2025-05-09 | English | ||
| 42395549 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-04-11 | English | ||
| 42385706 | Cessation | 2025-04-01 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Pfizer Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60507/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60507 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60507 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60507 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60507}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pfizer Ltd. (id: 60507)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.